FDA 483 - Lattice Inc - January 17, 2020
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Lattice Inc., a medical software device firm in Wheaton, IL, received a Form 483 with five observations primarily concerning inadequate quality system procedures. The firm failed to establish proper procedures for complaint investigations, design changes, corrective and preventive actions, complaint file maintenance, and control of non-conforming products, indicating significant deficiencies in its quality management system. These issues impact the safety and efficacy of its Medicopia software, particularly concerning blood/tissue transfusion verification.
ID · 46249901-a873-4ca1-9276-3c2e4ae10564